| 11/16/2026 9:02 AM | Dianthus Therapeutics (1690585) Subject T. Rowe Price Investment Management, Inc. (1897612) Filed by | Form SCHEDULE 13G/A | |
| 11/12/2026 4:32 PM | Dianthus Therapeutics (1690585) Issuer Savitz Ryan (1992324) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/09/2026 3:36 PM | Dianthus Therapeutics (1690585) Subject Savitz Ryan (1992324) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/30/2026 10:26 AM | Dianthus Therapeutics (1690585) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 09/18/2026 3:36 PM | CARR EDWARD (1273351) Reporting Dianthus Therapeutics (1690585) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/17/2026 3:28 PM | CARR EDWARD (1273351) Reporting Dianthus Therapeutics (1690585) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/01/2026 3:49 PM | Dianthus Therapeutics (1690585) Subject Randhawa Simrat (1992260) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/19/2026 5:02 PM | Dianthus Therapeutics (1690585) Issuer Read Simon (1688199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 7:33 AM | Dianthus Therapeutics (1690585) Subject Sirenia Capital Management LP (2115022) Filed by | Form SCHEDULE 13G/A | |
| 08/13/2026 3:05 PM | Dianthus Therapeutics (1690585) Subject WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by | Form SCHEDULE 13G | |
| 08/11/2026 4:08 PM | Dianthus Therapeutics (1690585) Issuer Veness Adam M (1778623) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for DNTH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Dianthus Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/11/2026 4:10 PM | Dianthus Therapeutics (1690585) Issuer Read Simon (1688199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/11/2026 4:15 PM | Dianthus Therapeutics (1690585) Issuer McGeorge Anne (1779934) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/10/2026 3:50 PM | Dianthus Therapeutics (1690585) Subject Veness Adam M (1778623) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/10/2026 3:33 PM | Dianthus Therapeutics (1690585) Subject McGeorge Anne (1779934) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/10/2026 3:34 PM | Dianthus Therapeutics (1690585) Subject Read Simon (1688199) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/07/2026 5:30 PM | Dianthus Therapeutics (1690585) Issuer Garcia Marino (1669866) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 3:37 PM | Dianthus Therapeutics (1690585) Subject Veness Adam M (1778623) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/07/2026 3:38 PM | Dianthus Therapeutics (1690585) Subject Garcia Marino (1669866) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/07/2026 3:18 PM | Dianthus Therapeutics (1690585) Subject Garcia Marino (1669866) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/07/2026 1:22 PM | Dianthus Therapeutics (1690585) Subject T. Rowe Price Investment Management, Inc. (1897612) Filed by | Form SCHEDULE 13G | |
| 08/07/2026 1:28 PM | Dianthus Therapeutics (1690585) Subject T. Rowe Price Investment Management, Inc. (1897612) Filed by | Form SCHEDULE 13G/A | |
| 08/04/2026 3:05 PM | Dianthus Therapeutics (1690585) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/13/2026 4:00 PM | Dianthus Therapeutics (1690585) Issuer Savitz Ryan (1992324) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2026 3:26 PM | Dianthus Therapeutics (1690585) Subject Savitz Ryan (1992324) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/18/2026 3:30 PM | Dianthus Therapeutics (1690585) Issuer Veness Adam M (1778623) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 3:33 PM | Dianthus Therapeutics (1690585) Subject Veness Adam M (1778623) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/12/2026 6:00 AM | Dianthus Therapeutics (1690585) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/02/2026 6:00 PM | Dianthus Therapeutics (1690585) Issuer Randhawa Simrat (1992260) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 7:13 AM | Dianthus Therapeutics (1690585) Subject Sirenia Capital Management LP (2115022) Filed by | Form SCHEDULE 13G | |
| 05/15/2026 6:24 AM | Dianthus Therapeutics (1690585) Subject WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by | Form SCHEDULE 13G/A | |
| 05/11/2026 4:00 PM | Dianthus Therapeutics (1690585) Issuer Soteropoulos Paula (1692444) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 3:03 PM | Dianthus Therapeutics (1690585) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/05/2026 3:06 PM | Dianthus Therapeutics (1690585) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/27/2026 3:12 PM | BlackRock, Inc. (2012383) Filed by Dianthus Therapeutics (1690585) Subject | Form SCHEDULE 13G | |
| 04/10/2026 3:52 PM | Dianthus Therapeutics (1690585) Issuer Savitz Ryan (1992324) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/09/2026 3:22 PM | Dianthus Therapeutics (1690585) Subject Savitz Ryan (1992324) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/09/2026 3:09 PM | Dianthus Therapeutics (1690585) Filer | Form DEF 14A | |
| 04/09/2026 3:10 PM | Dianthus Therapeutics (1690585) Filer | Form DEFA14A | |
| 04/09/2026 3:11 PM | Dianthus Therapeutics (1690585) Filer | Form ARS | |
| 04/01/2026 4:26 PM | Dianthus Therapeutics (1690585) Issuer Soteropoulos Paula (1692444) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Your free book is about to disappear (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link.
He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes |
| 04/01/2026 4:26 PM | Dianthus Therapeutics (1690585) Issuer Savitz Ryan (1992324) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/31/2026 3:21 PM | Dianthus Therapeutics (1690585) Subject Soteropoulos Paula (1692444) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/26/2026 5:00 PM | Dianthus Therapeutics (1690585) Issuer Soteropoulos Paula (1692444) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 7:00 AM | Dianthus Therapeutics (1690585) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/13/2026 7:30 PM | Dianthus Therapeutics (1690585) Issuer Randhawa Simrat (1992260) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 7:30 PM | CARR EDWARD (1273351) Reporting Dianthus Therapeutics (1690585) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 7:30 PM | Dianthus Therapeutics (1690585) Issuer Garcia Marino (1669866) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/12/2026 3:59 PM | Dianthus Therapeutics (1690585) Subject Garcia Marino (1669866) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/12/2026 3:23 PM | CARR EDWARD (1273351) Reporting Dianthus Therapeutics (1690585) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/12/2026 3:30 PM | Dianthus Therapeutics (1690585) Subject Randhawa Simrat (1992260) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/12/2026 6:20 AM | Dianthus Therapeutics (1690585) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/11/2026 4:28 PM | Dianthus Therapeutics (1690585) Filer | Form 424B5 | |
| 03/10/2026 8:54 PM | Dianthus Therapeutics (1690585) Filer | Form S-3MEF | |
| 03/09/2026 4:25 PM | Dianthus Therapeutics (1690585) Filer | Form 424B5 | |
| 03/09/2026 8:04 AM | Dianthus Therapeutics (1690585) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/09/2026 6:21 AM | Dianthus Therapeutics (1690585) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/09/2026 6:19 AM | Dianthus Therapeutics (1690585) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/04/2026 4:39 PM | Dianthus Therapeutics (1690585) Issuer Garcia Marino (1669866) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 4:40 PM | Dianthus Therapeutics (1690585) Issuer Savitz Ryan (1992324) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 4:40 PM | Dianthus Therapeutics (1690585) Issuer Randhawa Simrat (1992260) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 4:41 PM | Dianthus Therapeutics (1690585) Issuer Veness Adam M (1778623) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 4:42 PM | CARR EDWARD (1273351) Reporting Dianthus Therapeutics (1690585) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/01/2026 11:15 PM | Dianthus Therapeutics (1690585) Filer | Form EFFECT | |
| 01/28/2026 3:25 PM | Dianthus Therapeutics (1690585) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 01/12/2026 8:01 AM | Dianthus Therapeutics (1690585) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/05/2025 7:00 PM | Dianthus Therapeutics (1690585) Issuer Savitz Ryan (1992324) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/04/2025 3:42 PM | Dianthus Therapeutics (1690585) Subject Savitz Ryan (1992324) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/25/2025 8:00 PM | Dianthus Therapeutics (1690585) Subject Fairmount Funds Management LLC (1802528) Filed by | Form SCHEDULE 13D/A | |
| 11/19/2025 8:15 PM | Avidity Partners Management LP (1791827) Filed by Dianthus Therapeutics (1690585) Subject | Form SCHEDULE 13D/A | |